Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis
- PMID: 34620307
- PMCID: PMC8288213
- DOI: 10.1016/j.clnesp.2021.07.003
Prognostic properties of hypoalbuminemia in COVID-19 patients: A systematic review and diagnostic meta-analysis
Abstract
Background: Coronavirus disease 2019 (COVID-19) elicits robust inflammatory reaction that may result in a declining albumin serum level. This meta-analysis aimed to evaluate the prognostic properties of hypoalbuminemia for poor prognosis and factors that may influence the relationship.
Method: A systematic literature search of PubMed was conducted from inception to April 22, 2021. The main exposure was albumin level below normal range-defined by the included studies. The outcome of interest was composite poor outcome that comprises of mortality, severity, and the requirement of mechanical ventilation or intensive care unit.
Results: There were 6200 patients from 19 studies. Meta-analysis showed that hypoalbuminemia was associated with composite poor outcome (OR 6.97 (95% CI 4.20-11.55), p < 0.001; I2 = 91.3%, p < 0.001). Meta-regression analysis showed that age (p = 0.44), gender (p = 0.76), HT (p = 0.97), DM (p = 0.40), CKD (p = 0.65), liver disease (p = 0.72), and malignancy (p = 0.84) did not affect the association. Subgroup analysis showed that hypoalbuminemia increased mortality (OR 6.26 (95% CI 3.26-12.04), p < 0.001; I2 = 69.6%, p < 0.01) and severity of the disease (OR 7.32 (95%CI 3.94-13.59), p < 0.001; I2 = 92.5%, p < 0.01). Pooled diagnostic analysis of hypoalbuminemia yielded a sensitivity of 0.63 (95% CI 0.52-0.72), specificity of 0.81 (95% CI 0.73-0.87), and AUC of 0.77. The probability of poor outcome was 70% in patients with hypoalbuminemia and 24% in patients with normal albumin level.
Conclusion: Hypoalbuminemia was associated with poor prognosis in COVID-19 patients.
Keywords: Albumin; COVID-19; Hypoalbuminemia; Prognosis.
Copyright © 2021 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of competing interest None.
Figures
Similar articles
-
The prognostic values of thyroid disorders in predicting COVID-19 composite poor outcomes: A systematic review and meta-analysis.Diabetes Metab Syndr. 2022 May;16(5):102464. doi: 10.1016/j.dsx.2022.102464. Epub 2022 Mar 18. Diabetes Metab Syndr. 2022. PMID: 35508091 Free PMC article. Review.
-
Thrombocytopenia as a prognostic marker in COVID-19 patients: diagnostic test accuracy meta-analysis.Epidemiol Infect. 2021 Jan 29;149:e40. doi: 10.1017/S0950268821000236. Epidemiol Infect. 2021. PMID: 33509306 Free PMC article.
-
Higher albumin levels on admission predict better prognosis in patients with confirmed COVID-19.PLoS One. 2021 Mar 16;16(3):e0248358. doi: 10.1371/journal.pone.0248358. eCollection 2021. PLoS One. 2021. PMID: 33725003 Free PMC article.
-
Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia - A systematic review, meta-analysis, and meta-regression.Diabetes Metab Syndr. 2020 Jul-Aug;14(4):395-403. doi: 10.1016/j.dsx.2020.04.018. Epub 2020 Apr 17. Diabetes Metab Syndr. 2020. PMID: 32334395 Free PMC article.
-
The negative impact of obesity on the occurrence and prognosis of the 2019 novel coronavirus (COVID-19) disease: a systematic review and meta-analysis.Eat Weight Disord. 2022 Apr;27(3):893-911. doi: 10.1007/s40519-021-01269-3. Epub 2021 Jul 11. Eat Weight Disord. 2022. PMID: 34247342 Free PMC article. Review.
Cited by
-
COVID-19, Possible Hepatic Pathways and Alcohol Abuse-What Do We Know up to 2023?Int J Mol Sci. 2024 Feb 12;25(4):2212. doi: 10.3390/ijms25042212. Int J Mol Sci. 2024. PMID: 38396888 Free PMC article. Review.
-
Immunohematologic Biomarkers in COVID-19: Insights into Pathogenesis, Prognosis, and Prevention.Pathog Immun. 2023 Jun 26;8(1):17-50. doi: 10.20411/pai.v8i1.572. eCollection 2023. Pathog Immun. 2023. PMID: 37427016 Free PMC article. Review.
-
The role of cardiometabolic risk factors and endothelial dysfunction in serum albumin levels of patients with COVID-19.Cardiol J. 2022;29(6):1037-1039. doi: 10.5603/CJ.a2022.0088. Epub 2022 Sep 19. Cardiol J. 2022. PMID: 36117293 Free PMC article. No abstract available.
-
Risk Factors Associated with Mortality in COVID-19 Hospitalized Patients: Data from the Middle East.Int J Clin Pract. 2022 Aug 16;2022:9617319. doi: 10.1155/2022/9617319. eCollection 2022. Int J Clin Pract. 2022. PMID: 36072822 Free PMC article.
-
Association Between NOX2-Mediated Oxidative Stress, Low-Grade Endotoxemia, Hypoalbuminemia, and Clotting Activation in COVID-19.Antioxidants (Basel). 2024 Oct 17;13(10):1260. doi: 10.3390/antiox13101260. Antioxidants (Basel). 2024. PMID: 39456513 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous